{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:32:27Z","timestamp":1769603547697,"version":"3.49.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/mmy\/myz053","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T11:42:56Z","timestamp":1556106176000},"source":"Crossref","is-referenced-by-count":11,"title":["Resistance to echinocandin antifungal agents in the United Kingdom in clinical isolates of Candida glabrata: Fifteen years of interpretation and assessment"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4474-2391","authenticated-orcid":false,"given":"Mark","family":"Fraser","sequence":"first","affiliation":[{"name":"UK National Mycology Reference Laboratory, Public Health England, Bristol, UK"},{"name":"Centre for Research in Bioscience, University of the West of England, Coldharbour Lane, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M","family":"Borman","sequence":"additional","affiliation":[{"name":"UK National Mycology Reference Laboratory, Public Health England, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Thorn","sequence":"additional","affiliation":[{"name":"Centre for Research in Bioscience, University of the West of England, Coldharbour Lane, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynne M","family":"Lawrance","sequence":"additional","affiliation":[{"name":"Centre for Research in Bioscience, University of the West of England, Coldharbour Lane, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,5,21]]},"reference":[{"key":"2019052104502619200_bib1","doi-asserted-by":"crossref","first-page":"18026","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive candidiasis","volume":"11","author":"Pappas","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2019052104502619200_bib2","doi-asserted-by":"crossref","first-page":"e101510","DOI":"10.1371\/journal.pone.0101510","article-title":"Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2496 patients: data from the prospective antifungal therapy (PATH) registry 2004\u20132008","volume":"9","author":"Pfaller","year":"2014","journal-title":"PLoS One"},{"key":"2019052104502619200_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12539","article-title":"Global trends in the distribution of Candida species causing candidaemia","volume":"20","author":"Guinea","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"2019052104502619200_bib4","first-page":"B5288","article-title":"Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment","volume":"63","author":"Jansen","year":"2016","journal-title":"Dan Med J"},{"key":"2019052104502619200_bib5","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/jac\/dkt508","article-title":"Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology","volume":"69","author":"Ashbee","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2019052104502619200_bib6","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s10096-018-3312-9","article-title":"Economic evaluation of micafungin versus liposomal amphotericin b (LAmB) for treating patients with candidaemia and invasive candidiasis (IC) in Turkey","volume":"37","author":"Neoh","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2019052104502619200_bib7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/myc.12816","article-title":"Epidemiology of fungaemia in Sweden: a nationwide retrospective observational study","volume":"61","author":"Klingspor","year":"2018","journal-title":"Mycoses"},{"key":"2019052104502619200_bib8","first-page":"fov114","article-title":"Old and new pathogenic Nakaseomyces species: epidemiology, biology, identification, pathogenicity and antifungal resistance","volume":"16","author":"Angoulvant","year":"2016","journal-title":"FEMS Yeast Res"},{"key":"2019052104502619200_bib9","doi-asserted-by":"crossref","first-page":"e00591","DOI":"10.1128\/AAC.00591-18","article-title":"Clonal spread of Candida glabrata bloodstream isolates and fluconazole resistance affected by prolonged exposure: a 12 year single-center study in Belgium","volume":"62","author":"Goemaere","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2019052104502619200_bib10","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s15010-018-1139-z","article-title":"Evaluation of candidaemia and antifungal consumption in a large tertiary care Italian hospital over a 12-year period","volume":"46","author":"Mencarini","year":"2018","journal-title":"Infection"},{"key":"2019052104502619200_bib11","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1177\/1060028015590838","article-title":"Is fluconazole or an echinocandin the agent of choice for candidaemia","volume":"49","author":"Eschenauer","year":"2015","journal-title":"Ann Pharmacother"},{"key":"2019052104502619200_bib12","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1128\/AAC.02189-13","article-title":"Breakthrough candidaemia due to multidrug-resistant Candida glabrata during prophylaxis with a low dose of micafungin","volume":"58","author":"Bizerra","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2019052104502619200_bib13","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2019052104502619200_bib14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12281-014-0209-7","article-title":"Epidemiology of echinocandin resistance in Candida","volume":"8","author":"Grossman","year":"2014","journal-title":"Curr Fungal Infect Rep"},{"key":"2019052104502619200_bib15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jgar.2018.06.009","article-title":"Micafungin use in a UK tertiary referral hospital","volume":"15","author":"Enoch","year":"2018","journal-title":"J Glob Antimicrob Resist"},{"key":"2019052104502619200_bib16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jinf.2018.05.011","article-title":"Effectiveness of echinocandins versus fluconazole for the treatment of persistent candidaemia: a time-dependent analysis","volume":"77","author":"Lin","year":"2018","journal-title":"J Infect"},{"key":"2019052104502619200_bib17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1128\/AAC.01256-09","article-title":"Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media","volume":"54","author":"Arendrup","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2019052104502619200_bib18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.diagmicrobio.2014.03.004","article-title":"Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested against Candida spp","volume":"79","author":"Pfaller","year":"2014","journal-title":"Diag Microbiol Infect Dis"},{"key":"2019052104502619200_bib19","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1128\/AAC.01519-13","article-title":"Interlaboratory variability of caspofungin MICs for Candida spp. using CLSI and EUCAST methods: should the clinical laboratory be testing this agent","volume":"57","author":"Espinel-Ingroff","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2019052104502619200_bib20","doi-asserted-by":"crossref","first-page":"e00162","DOI":"10.1128\/AAC.00162-18","article-title":"Resistance to echinocandins in Candida can be detected by performing the Etest directly on blood culture samples","volume":"62","author":"Bordallo-Cardona","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2019052104502619200_bib21","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1128\/AAC.41.11.2471","article-title":"Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors","volume":"41","author":"Douglas","year":"1997","journal-title":"Antimicrob Agents. Chemother."},{"key":"2019052104502619200_bib22","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1128\/AAC.03255-14","article-title":"Role of FKS mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance","volume":"58","author":"Pham","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2019052104502619200_bib23","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.1128\/AAC.00813-12","article-title":"Fks1 and Fks2 are functionally redundant but differentially regulated in Candida glabrata: implications for echinocandin resistance","volume":"56","author":"Katiyar","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2019052104502619200_bib24","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1128\/AAC.00123-14","article-title":"Positions and numbers of FKS mutations in Candida albicans selectively influence in vitro and in vivo susceptibilities to echinocandin treatment","volume":"58","author":"Lackner","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2019052104502619200_bib25","first-page":"5042","article-title":"The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata","volume":"54","author":"Shields","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2019052104502619200_bib26","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1128\/JCM.03489-13","article-title":"Evaluation of a short, on-plate formic acid extraction method for matrix-assisted laser desorption ionization-time of flight mass spectrometry-based identification of clinically relevant yeast isolates","volume":"52","author":"Gorton","year":"2014","journal-title":"J Clin Microbiol"},{"key":"2019052104502619200_bib27","first-page":"80","article-title":"Rapid identification of 6328 isolates of pathogenic yeasts using MALDI-TOF MS and a simplified, rapid extraction procedure that is compatible with the Bruker Biotyper platform and database","volume":"54","author":"Fraser","year":"2016","journal-title":"Med Mycol"},{"key":"2019052104502619200_bib28","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1128\/JCM.01071-10","article-title":"Rapid molecular identification of pathogenic yeasts by pyrosequencing analysis of 35 nucleotides of internal transcribed spacer","volume":"48","author":"Borman","year":"2010","journal-title":"J Clin Microbiol"},{"key":"2019052104502619200_bib29","doi-asserted-by":"crossref","first-page":"9909","DOI":"10.1038\/s41598-017-09329-4","article-title":"Potential use of MALDI-ToF mass spectrometry for rapid detection of antifungal resistance in the human pathogen Candida glabrata","volume":"7","author":"Vella","year":"2017","journal-title":"Sci Rep"},{"key":"2019052104502619200_bib30","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1128\/AAC.01574-16","article-title":"Rapid detection of FKS-associated echinocandin resistance in Candida glabrata","volume":"60","author":"Zhao","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2019052104502619200_bib31","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1128\/JCM.01038-14","article-title":"Set of classical PCRs for the detection of mutations in Candida glabrata FKS genes linked with echinocandin resistance","volume":"52","author":"Dudiuk","year":"2014","journal-title":"J Clin Microbiol"},{"key":"2019052104502619200_bib32","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1128\/JCM.02061-06","article-title":"Molecular identification of unusual oathogenic yeast isolates by large ribosomal subunit gene sequencing: 2 years of experience at the United Kingdom Mycology Reference Laboratory","volume":"45","author":"Linton","year":"2007","journal-title":"J Clin Microbiol"},{"key":"2019052104502619200_bib33","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1128\/JCM.00566-08","article-title":"Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints","volume":"46","author":"Pfaller","year":"2008","journal-title":"J Clin Microbiol"},{"key":"2019052104502619200_bib34","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drup.2011.01.004","article-title":"Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical and microbiological data to arrive at species- specific interpretive criteria","volume":"14","author":"Pfaller","year":"2011","journal-title":"Drug Resist Updates"},{"key":"2019052104502619200_bib35","volume-title":"Reference method for broth dilution testing of yeast","author":"National Committee for Clinical Laboratory Standards","year":"2002","edition":"2nd edn"},{"key":"2019052104502619200_bib36","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts","author":"Clinical Laboratory Standards Institute","year":"2017","edition":"4th edn"},{"key":"2019052104502619200_bib37","volume-title":"Performance standards for antifungal susceptibility testing of yeasts","author":"Clinical Laboratory Standards Institute","year":"2017","edition":"1st edn"},{"key":"2019052104502619200_bib38","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1128\/AAC.01451-13","article-title":"Anidulafungin and micafungin MIC breakpoints are superior to that of caspofungin for identifying FKS mutant Candida glabrata strains and echinocandin resistance","volume":"57","author":"Shields","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2019052104502619200_bib39","doi-asserted-by":"crossref","first-page":"12907","DOI":"10.1073\/pnas.91.26.12907","article-title":"The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an intergral membrane protein which is a subunit of 1,3-beta-D-glucan synthase","volume":"91","author":"Douglas","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019052104502619200_bib40","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1128\/AAC.49.8.3264-3273.2005","article-title":"Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates","volume":"49","author":"Park","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2019052104502619200_bib41","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/jac\/dks112","article-title":"Reconstitution of high-level micafungin resistance detected in a clinical isolate of Candida glabrata identifies functional homozygosity in glucan synthase gene expression","volume":"67","author":"Niimi","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2019052104502619200_bib42","doi-asserted-by":"crossref","first-page":"e01564","DOI":"10.1128\/JCM.01564-17","article-title":"Update from a 12-year nationwide fungemia surveillance: increasing intrinsic and acquired resistance causes concern","volume":"56","author":"Astvad","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2019052104502619200_bib43","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3389\/fmicb.2017.00880","article-title":"Molecular epidemiology and antifungal susceptibility of Candida glabrata in China (August 2009 to July 2014): a multi-center study","volume":"8","author":"Hou","year":"2017","journal-title":"Front Microbiol"},{"key":"2019052104502619200_bib44","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1128\/AAC.02670-14","article-title":"Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center","volume":"58","author":"Marcos-Zambrano","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2019052104502619200_bib45","doi-asserted-by":"crossref","first-page":"e00420","DOI":"10.1128\/JCM.00420-18","article-title":"MBT ASTRA: Proof-of-concept for a rapid MALDI-TOF MS based method to detect caspofungin resistance in Candida albicans and Candida glabrata","volume":"56","author":"Vatanshenassan","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2019052104502619200_bib46","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.diagmicrobio.2014.11.014","article-title":"Evaluation of real-time PCR and pyrosequencing for screening incubating blood culture bottles from adults with suspected bloodstream infection","volume":"81","author":"McCann","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2019052104502619200_bib47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/JCM.02394-15","article-title":"Direct screening of blood by PCR and pyrosequencing for a 16S rRNA gene target from emergency department and intensive care unit patients being evaluated for bloodstream infection","volume":"54","author":"Moore","year":"2016","journal-title":"J Clin Microbiol"},{"key":"2019052104502619200_bib48","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1093\/jac\/dky059","article-title":"Echinocandin resistance among Candida isolates at an academic medical centre 2005\u201315: analysis of trends and outcomes","volume":"73","author":"McCarty","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2019052104502619200_bib49","doi-asserted-by":"crossref","first-page":"e02299","DOI":"10.1128\/AAC.02299-17","article-title":"FKS2 and FKS3 genes of opportunistic human pathogen Candida albicans influence echinocandin susceptibility","volume":"62","author":"Suwunnakorn","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2019052104502619200_bib50","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11046-006-0023-z","article-title":"Evaluation of the viability of pathogenic filamentous fungi after prolonged storage in sterile water and review of recent published studies on storage methods","volume":"161","author":"Borman","year":"2006","journal-title":"Mycopathologia"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myz053\/28678252\/myz053.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T19:29:51Z","timestamp":1663356591000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/advance-article\/doi\/10.1093\/mmy\/myz053\/5492542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,21]]},"references-count":50,"URL":"https:\/\/doi.org\/10.1093\/mmy\/myz053","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,21]]},"article-number":"myz053"}}